{"id":418640,"date":"2026-08-27T22:28:19","date_gmt":"2026-08-27T22:28:19","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-tx\/418640\/"},"modified":"2026-08-27T22:28:19","modified_gmt":"2026-08-27T22:28:19","slug":"houston-named-top-emerging-u-s-biopharma-cluster-in-new-ranking","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-tx\/418640\/","title":{"rendered":"Houston Named Top Emerging U.S. Biopharma Cluster in New Ranking"},"content":{"rendered":"<p>Houston ranks No.1 in the nation for emerging biopharma clusters, according to Genetic Engineering &amp; Biotechnology News\u2019 inaugural <a href=\"https:\/\/www.genengnews.com\/topics\/drug-discovery\/next-10-u-s-biopharma-clusters\/\" rel=\"nofollow noopener\" target=\"_blank\">Next 10 U.S. Biopharma Clusters<\/a> list.\u00a0<\/p>\n<p>The recognition comes less than a month after Bristol Myers Squibb <a href=\"https:\/\/www.houston.org\/news\/bristol-myers-squibb-facility\" rel=\"nofollow noopener\" target=\"_blank\">announced<\/a> a $2.3 billion investment in Houston.\u00a0<\/p>\n<p>GEN\u2019s new list highlights\u00a0emerging life sciences hubs outside\u00a0of traditional markets\u00a0like\u00a0Boston\/Cambridge and the San Francisco Bay Area.\u00a0<\/p>\n<p>What Put Houston at No. 1?\u00a0<\/p>\n<p>GEN evaluated emerging regions based on five factors: patents, NIH funding, venture capital investment, laboratory space and life sciences employment.\u00a0<\/p>\n<p>Houston led in NIH funding, with 2,262 awards totaling $1.25 billion from 2025 through July 6, 2026, according to the report. The region ranked second in life sciences employment, with more than 28,000 jobs, and laboratory space, with approximately eight million square feet.\u00a0BioHouston Chairman Jeff Wade told GEN that Houston secured about $500 million in venture capital funding in 2025 and 2026 to date.\u00a0<\/p>\n<p>What Is Driving Houston\u2019s Biopharma Growth?\u00a0<\/p>\n<p>Houston continues to attract major biopharma investment.\u00a0Last year, Eli Lilly announced a $6.5 billion, 236-acre manufacturing facility at Generation Park, expected to create more than 615 full-time jobs. Bristol Myers Squibb followed with plans for a 600,000-square-foot manufacturing campus at Generation Park, creating nearly 500 skilled jobs.\u00a0<\/p>\n<p>READ MORE:\u00a0<a href=\"https:\/\/www.houston.org\/news\/houston-wins-texas-first-big-pharma-plant-with-6-5b-investment\/\" rel=\"nofollow noopener\" target=\"_blank\">Houston Wins Texas\u2019 First Major Pharma Plant With $6.5B Investment<\/a>\u00a0<\/p>\n<p>Houston\u2019s startup ecosystem is also gaining traction. Lilly recently expanded its regional footprint by acquiring local biotech startup CrossBridge Bio for up to $300 million.\u00a0<\/p>\n<p>GET THE BACKSTORY: <a href=\"https:\/\/www.houston.org\/news\/eli-lilly-to-acquire-houston-biotech-startup-crossbridge-bio\/\" rel=\"nofollow noopener\" target=\"_blank\">Eli Lilly to Acquire Houston Biotech Startup CrossBridge Bio<\/a>\u00a0<\/p>\n<p>Duracyte, launched out of Rice University\u2019s biotech venture studio RBL LLC, is working to commercialize technology designed to continuously produce therapeutic proteins inside the body.\u00a0<\/p>\n<p>\u201cThere\u2019s a lot of great talent,\u201d\u00a0Duracyte co-founder Omid Veiseh told GEN.\u00a0\u201cBut the unique advantage that we have is we are able to benefit from a lot of unique clinical infrastructure and clinician insights.\u201d<\/p>\n<p>Houston\u2019s life sciences ecosystem is built to support companies at every stage, from startup and commercialization to large-scale manufacturing. The region combines the clinical reach of the Texas Medical Center, leading research institutions and specialized workforce training through programs like San Jacinto College\u2019s NIBRT-licensed Center for Biotechnology.\u00a0<\/p>\n<p>Explore <a href=\"https:\/\/houston.org\/why-houston\/industries\/life-sciences-biotechnology\/\" rel=\"nofollow noopener\" target=\"_blank\">Houston\u2019s life sciences ecosystem<\/a>.\u00a0\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Houston ranks No.1 in the nation for emerging biopharma clusters, according to Genetic Engineering &amp; Biotechnology News\u2019 inaugural&hellip;\n","protected":false},"author":2,"featured_media":63577,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[56,58,57],"class_list":["post-418640","post","type-post","status-publish","format-standard","has-post-thumbnail","category-houston","tag-houston","tag-houston-headlines","tag-houston-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/418640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/comments?post=418640"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/418640\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media\/63577"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media?parent=418640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/categories?post=418640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/tags?post=418640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}